Publications by authors named "Susan Manzi"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,493

Total Likes

11

Extended Reach

15,346

Social Features

3
C
Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials.
Ian N Bruce, Richard A Furie, Eric F Morand, Susan Manzi, Yoshiya Tanaka, Kenneth C Kalunian, Joan T Merrill, Patricia Puzio, Emmanuelle Maho, Christi Kleoudis

Ann Rheum Dis· July 2022

Videos about Article: user

1 2 2

View All Article and Social Media Activity
D
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug Monitoring.
Shivani Garg, Benoît Blanchet, Yann Nguyen, Fauzia Hollnagel, Ada Clarke, Susan Manzi

Arthritis Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality.
Yann L C Becker, Éric Boilard, Emmanuelle Rollet-Labelle, Christian Lood, Anne-Sophie Julien, Susan Manzi

Ann Rheum Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Patients Within the Rheumatoid Arthritis Care Pathway Cohort at a Tertiary Care Integrated Delivery Network: A Comparison to Usual Care.
Tarun Sharma, Tyson S Barrett, Teigan Dwyer, Nancy Campbell, Jessica Heintzinger, Susan Manzi

Arthritis Care Res (Hoboken)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of belimumab on mucocutaneous and vasculitis manifestations in patients with systemic lupus erythematosus: A large pooled post hoc analysis.
Susan Manzi, Jorge Sánchez-Guerrero, Naoto Yokogawa, Joerg Wenzel, Josephine C Ocran-Appiah

Lupus· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trials.
Eric F Morand, Ronald van Vollenhoven, Richard A Furie, Kenneth C Kalunian, Susan Manzi

Ann Rheum Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A charter to improve care for systemic lupus erythematosus.
Marta Mosca, Jeanette Andersen, Patrick Wildman, Susan Manzi, Zahir Amoura

Clin Exp Rheumatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-centered clinical validation demonstrating superior precision in lupus diagnosis: T cell autoantibodies and TC4d outperform conventional lupus erythematosus biomarkers.
Vasileios Kyttaris, Daniel J Wallace, Arezou Khosroshahi, Andrew Concoff, Nicole Wilson, Susan Manzi

Front Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In response to: "Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee" by Greco et al.
James F Howard, Susan M Manzi, Milos D Miljkovic, Tuan Vu, Tahseen Mozaffar

EClinicalMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Megan R W Barber, Manuel Francisco Ugarte-Gil, John G Hanly, Murray B Urowitz, Yvan St-Pierre, Susan Manzi

Ann Rheum Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus.
Eugene Krustev, John G Hanly, Ricky Chin, Katherine A Buhler, Murray B Urowitz, Susan Manzi

Lupus Sci Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment approaches and costs associated with diabetes clinical metrics as measured by Healthcare Effectiveness Data and Information Set (HEDIS).
Jamil Alkhaddo, Jillian M Rung, Ameer Khowaja, Yue Yin, Shannon B Richards, Susan Manzi

BMC Health Serv Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort.
Yann Nguyen, Benoît Blanchet, Murray B Urowitz, John G Hanly, Caroline Gordon, Susan Manzi

Arthritis Rheumatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling.
Ann E Clarke, John G Hanly, Murray B Urowitz, Yvan St Pierre, Caroline Gordon, Susan Manzi

Arthritis Care Res (Hoboken)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
May Yee Choi, Irene Chen, Ann Elaine Clarke, Marvin J Fritzler, Katherine A Buhler, Susan Manzi

Ann Rheum Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Construct of Damage in Systemic Lupus Erythematosus.
Sindhu R Johnson, Dafna D Gladman, Hermine I Brunner, David Isenberg, Ann E Clarke, Susan Manzi

Arthritis Care Res (Hoboken)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: a post hoc analysis of the TULIP-1 and TULIP-2 trials.
Ian N Bruce, Ronald F van Vollenhoven, Eric F Morand, Richard A Furie, Susan Manzi

Rheumatology (Oxford)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: disease mechanisms and medical management of calcium nephrolithiasis in rheumatologic diseases.
Omar Osman, Susan Manzi, Mary Chester Wasko, Barbara A Clark

BMC Urol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus.
Kenneth C Kalunian, Richard Furie, Eric F Morand, Ian N Bruce, Susan Manzi

Arthritis Rheumatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lupus spectrum ambiguity has long-term negative implications for patients.
Ian N Bruce, Joy Buie, Lauren Bloch, Sang-Cheol Bae, Karen Costenbader, Susan Manzi

Lupus Sci Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Manuel Francisco Ugarte-Gil, John Hanly, Murray Urowitz, Caroline Gordon, Sang-Cheol Bae, Susan Manzi

Ann Rheum Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine.
Celline C Almeida-Brasil, John G Hanly, Murray Urowitz, Ann Elaine Clarke, Guillermo Ruiz-Irastorza, Susan Manzi

Lupus Sci Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic.
Francesca S Cardwell, Susan J Elliott, Ricky Chin, Yvan St Pierre, May Y Choi, Susan Manzi

Lupus Sci Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
May Yee Choi, Ann Elaine Clarke, Murray Urowitz, John Hanly, Yvan St-Pierre, Susan Manzi

Ann Rheum Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials.
Edward M Vital, Joan T Merrill, Eric F Morand, Richard A Furie, Ian N Bruce, Susan Manzi

Ann Rheum Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis